CLINICAL USE


Vitamin B6

DOSE IN NORMAL RENAL FUNCTION

Deficiency:
  • 20 to 50 &nbsp &nbsp : mg up to 3 times daily Prophylaxis against isoniazid neuropathy:
  • 10 to 20 &nbsp &nbsp : mg daily; 50 mg 3 times daily for treatmentIdiopathic sideroblastic anaemia: 100– 400 mg daily in divided dosesPremenstrual syndrome: 50–100 mg daily

    PHARMACOKINETICS

  • Molecular weight &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :205.6
  • %Protein binding &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :High (as pyridoxal and pyridoxal phosphate)
  • %Excreted unchanged in urine &nbsp &nbsp : No data
  • Volume of distribution (L/kg) &nbsp &nbsp &nbsp :No data
  • half-life – normal/ESRD (hrs)&nbsp &nbsp &nbsp :15–20 days

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50 &nbsp &nbsp : Dose as in normal renal function
  • 10 to 20 &nbsp &nbsp : Dose as in normal renal function
  • <10 &nbsp &nbsp &nbsp &nbsp &nbsp : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp:Unknown dialysability. Dose as in normal renal function

  • HD &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :Dialysed. Dose as in normal renal function
  • HDF/high flux &nbsp :Dialysed. Dose as in normal renal function
  • CAV/VVHD &nbsp &nbsp &nbsp:Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • None known

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Long-term use of pyridoxine in doses greater than 200 mg daily has been associated with neuropathy